CLINICAL_TRIALS
trial_result
· 2012-08-21
Clinical Trial Update: Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia [Phase 3]
Summary
A long-term Phase 3 trial of lurasidone hydrochloride in chronic schizophrenia completed, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sumitomo Pharma America, Inc. | Conditions: Chronic Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2012-08-21